Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.

Inker LA, Heerspink HJL, Tighiouart H, Levey AS, Coresh J, Gansevoort RT, Simon AL, Ying J, Beck GJ, Wanner C, Floege J, Li PK, Perkovic V, Vonesh EF, Greene T.

J Am Soc Nephrol. 2019 Sep;30(9):1735-1745. doi: 10.1681/ASN.2019010007. Epub 2019 Jul 10.

PMID:
31292197
2.

Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.

Kubiak RW, Zelnick LR, Hoofnagle AN, Alpers CE, Terry CM, Shiu YT, Cheung AK, de Boer IH, Robinson-Cohen C, Allon M, Dember LM, Feldman HI, Himmelfarb J, Huber TS, Roy-Chaudhury P, Vazquez MA, Kusek JW, Beck GJ, Imrey PB, Kestenbaum B; Hemodialysis Fistula Maturation Study Group.

Eur J Vasc Endovasc Surg. 2019 May;57(5):719-728. doi: 10.1016/j.ejvs.2019.01.022. Epub 2019 Apr 15.

PMID:
31000459
3.

The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.

Huang SS, Kaysen GA, Levin NW, Kliger AS, Beck GJ, Rocco MV, Filler G, Lindsay RM; Frequent Hemodialysis Network (FHN) Group.

Hemodial Int. 2019 Jul;23(3):297-305. doi: 10.1111/hdi.12749. Epub 2019 Mar 12.

PMID:
30861262
4.

Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study.

Robbin ML, Greene T, Allon M, Dember LM, Imrey PB, Cheung AK, Himmelfarb J, Huber TS, Kaufman JS, Radeva MK, Roy-Chaudhury P, Shiu YT, Vazquez MA, Umphrey HR, Alexander L, Abts C, Beck GJ, Kusek JW, Feldman HI; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2018 Nov;29(11):2735-2744. doi: 10.1681/ASN.2017111225. Epub 2018 Oct 11.

PMID:
30309898
5.

Body mass index, calcium supplementation and risk of colorectal adenomas.

Barry EL, Lund JL, Westreich D, Mott LA, Ahnen DJ, Beck GJ, Bostick RM, Bresalier RS, Burke CA, Church TR, Rees JR, Robertson DJ, Baron JA.

Int J Cancer. 2019 Feb 1;144(3):448-458. doi: 10.1002/ijc.31803. Epub 2018 Oct 30.

PMID:
30117164
6.

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Wang K, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group.

Am J Nephrol. 2018;48(1):56-64. doi: 10.1159/000491828. Epub 2018 Aug 2.

7.

Alteration of HDL Protein Composition with Hemodialysis Initiation.

Wang K, Zelnick LR, Hoofnagle AN, Vaisar T, Henderson CM, Imrey PB, Robinson-Cohen C, de Boer IH, Shiu YT, Himmelfarb J, Beck GJ, Kestenbaum B; HFM Study.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1225-1233. doi: 10.2215/CJN.11321017. Epub 2018 Jul 25.

8.

The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.

Gupta N, Lee HS, Ryu JH, Taveira-DaSilva AM, Beck GJ, Lee JC, McCarthy K, Finlay GA, Brown KK, Ruoss SJ, Avila NA, Moss J, McCormack FX; NHLBI LAM Registry Group.

Chest. 2019 Feb;155(2):288-296. doi: 10.1016/j.chest.2018.06.016. Epub 2018 Jun 22.

PMID:
29940164
9.

Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.

Chan CT, Kaysen GA, Beck GJ, Li M, Lo J, Rocco MV, Kliger AS; FHN Trials.

Am J Nephrol. 2018;47(3):208-217. doi: 10.1159/000488003. Epub 2018 Apr 5.

10.

Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study.

Allon M, Imrey PB, Cheung AK, Radeva M, Alpers CE, Beck GJ, Dember LM, Farber A, Greene T, Himmelfarb J, Huber TS, Kaufman JS, Kusek JW, Roy-Chaudhury P, Robbin ML, Vazquez MA, Feldman HI; Hemodialysis Fistula Maturation (HFM) Study Group.

Am J Kidney Dis. 2018 May;71(5):677-689. doi: 10.1053/j.ajkd.2017.10.027. Epub 2018 Feb 2.

11.

PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.

Hemnes AR, Beck GJ, Newman JH, Abidov A, Aldred MA, Barnard J, Berman Rosenzweig E, Borlaug BA, Chung WK, Comhair SAA, Erzurum SC, Frantz RP, Gray MP, Grunig G, Hassoun PM, Hill NS, Horn EM, Hu B, Lempel JK, Maron BA, Mathai SC, Olman MA, Rischard FP, Systrom DM, Tang WHW, Waxman AB, Xiao L, Yuan JX, Leopold JA; PVDOMICS Study Group.

Circ Res. 2017 Oct 27;121(10):1136-1139. doi: 10.1161/CIRCRESAHA.117.311737. No abstract available.

12.

Association between change in serum bicarbonate and change in thyroid hormone levels in patients receiving conventional or more frequent maintenance haemodialysis.

Molfino A, Beck GJ, Li M, Lo JC, Kaysen GA; FHN Investigators.

Nephrology (Carlton). 2019 Jan;24(1):81-87. doi: 10.1111/nep.13187.

PMID:
29064128
13.

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Kikuchi M, Shobu Y.

Clin Exp Nephrol. 2018 Apr;22(2):299-308. doi: 10.1007/s10157-017-1447-0. Epub 2017 Jul 24.

14.

Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Alpers CE, Imrey PB, Hudkins KL, Wietecha TA, Radeva M, Allon M, Cheung AK, Dember LM, Roy-Chaudhury P, Shiu YT, Terry CM, Farber A, Beck GJ, Feldman HI, Kusek JW, Himmelfarb J; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2017 Oct;28(10):3076-3088. doi: 10.1681/ASN.2016050598. Epub 2017 Jul 19.

15.

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Newman JH, Rich S, Abman SH, Alexander JH, Barnard J, Beck GJ, Benza RL, Bull TM, Chan SY, Chun HJ, Doogan D, Dupuis J, Erzurum SC, Frantz RP, Geraci M, Gillies H, Gladwin M, Gray MP, Hemnes AR, Herbst RS, Hernandez AF, Hill NS, Horn EM, Hunter K, Jing ZC, Johns R, Kaul S, Kawut SM, Lahm T, Leopold JA, Lewis GD, Mathai SC, McLaughlin VV, Michelakis ED, Nathan SD, Nichols W, Page G, Rabinovitch M, Rich J, Rischard F, Rounds S, Shah SJ, Tapson VF, Lowy N, Stockbridge N, Weinmann G, Xiao L.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1661-1670. doi: 10.1164/rccm.201701-0150WS.

16.

Thyroid function in end stage renal disease and effects of frequent hemodialysis.

Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Li M, Chertow GM; FHN Study.

Hemodial Int. 2017 Oct;21(4):534-541. doi: 10.1111/hdi.12527. Epub 2017 Mar 16.

PMID:
28301073
17.

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.

Sirich TL, Fong K, Larive B, Beck GJ, Chertow GM, Levin NW, Kliger AS, Plummer NS, Meyer TW; Frequent Hemodialysis Network (FHN) Trial Group.

Kidney Int. 2017 May;91(5):1186-1192. doi: 10.1016/j.kint.2016.11.002. Epub 2017 Jan 12.

PMID:
28089366
18.

Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.

Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM; FHN Study.

Hemodial Int. 2017 Apr;21(2):190-196. doi: 10.1111/hdi.12489. Epub 2016 Oct 23.

PMID:
27774730
19.

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Shobu Y, Kikuchi M.

BMC Nephrol. 2016 Sep 30;17(1):141.

20.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators.

Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.

21.

Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study.

Dember LM, Imrey PB, Duess MA, Hamburg NM, Larive B, Radeva M, Himmelfarb J, Kraiss LW, Kusek JW, Roy-Chaudhury P, Terry CM, Vazquez MA, Vongpatanasin W, Beck GJ, Vita JA; Hemodialysis Fistula Maturation Study GroupFeldmanH.FarberA.KaufmanJ.SternL.LeSageP.KivorkC.SoaresD.MalikovaM.AllonM.YoungC.TaylorM.WoodardL.MangadiK.MundaR.LeeT.AllowayR.El‐KhatibM.CanaanT.PflumA.ThiekenL.Campos‐NaciffB.HuberT.BerceliS.JansenM.McCaslinG.TrahanY.DavidsonI.HwangC.LightfootT.LivingstonC.ValenciaA.DolmatchB.FenvesA.HawkinsN.CheungA.KinikiniD.TreimanG.IhnatD.SarfatiM.LavasaniI.MaloneyM.SchlotfeldtL.BuchananC.ClarkC.CrawfordC.HamlettJ.KundzinsJ.ManahanL.WiseJ.GassmanJ.GreeneT.LiL.

J Am Heart Assoc. 2016 Jul 22;5(7). pii: e003227. doi: 10.1161/JAHA.116.003227.

22.

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD.

Leonberg-Yoo AK, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ.

Am J Kidney Dis. 2017 Mar;69(3):341-349. doi: 10.1053/j.ajkd.2016.03.431. Epub 2016 May 24.

23.

Class of cooperative stochastic models: Exact and approximate solutions, simulations, and experiments using ionic self-assembly of nanoparticles.

Mazilu I, Mazilu DA, Melkerson RE, Hall-Mejia E, Beck GJ, Nshimyumukiza S, da Fonseca CM.

Phys Rev E. 2016 Mar;93(3):032803. doi: 10.1103/PhysRevE.93.032803. Epub 2016 Mar 25.

PMID:
27078429
24.

Long-Term Effects of Frequent In-Center Hemodialysis.

Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T; Frequent Hemodialysis Network (FHN) Trials Group.

J Am Soc Nephrol. 2016 Jun;27(6):1830-6. doi: 10.1681/ASN.2015040426. Epub 2015 Oct 14.

25.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

26.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS.

Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.

27.

The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts.

Farber A, Tan TW, Hu B, Dember LM, Beck GJ, Dixon BS, Kusek JW, Feldman HI; Dialysis Access Consortium (DAC) Study Group; Dialysis Access Consortium DAC Study Group.

J Vasc Surg. 2015 Nov;62(5):1258-64. doi: 10.1016/j.jvs.2015.06.132. Epub 2015 Aug 6.

28.

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.

Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2015 Sep;66(3):459-68. doi: 10.1053/j.ajkd.2015.02.331. Epub 2015 Apr 8.

29.

Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.

Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, Greene T, Larive B, Beck GJ, Gassman J, Kliger AS, Stokes JB; FHN Trial Group.

Hemodial Int. 2015 Jul;19(3):386-401. doi: 10.1111/hdi.12255. Epub 2015 Jan 5.

30.

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Arita K, Kato A, Shimizu M.

J Am Soc Nephrol. 2015 Jul;26(7):1732-46. doi: 10.1681/ASN.2014010042. Epub 2014 Oct 27.

31.

Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease.

Fan L, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ.

Kidney Int. 2014 Sep;86(3):582-8. doi: 10.1038/ki.2014.59. Epub 2014 Mar 19.

32.

Objectives and design of the hemodialysis fistula maturation study.

Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, Kusek JW, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Vita JA, Greene T, Gassman JJ, Feldman HI; Hemodialysis Fistula Maturation Study Group.

Am J Kidney Dis. 2014 Jan;63(1):104-12. doi: 10.1053/j.ajkd.2013.06.024. Epub 2013 Aug 28.

33.

Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2106-16. doi: 10.2215/CJN.03280313. Epub 2013 Aug 22.

34.

Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study.

Newsome B, Ix JH, Tighiouart H, Sarnak MJ, Levey AS, Beck GJ, Block G.

Am J Kidney Dis. 2013 Jun;61(6):1045-6. doi: 10.1053/j.ajkd.2013.01.007. Epub 2013 Feb 13. No abstract available.

PMID:
23415016
35.

Accuracy of a GFR estimating equation over time in people with a wide range of kidney function.

Padala S, Tighiouart H, Inker LA, Contreras G, Beck GJ, Lewis J, Steffes M, Rodby RA, Schmid CH, Levey AS.

Am J Kidney Dis. 2012 Aug;60(2):217-24. doi: 10.1053/j.ajkd.2012.01.024. Epub 2012 Apr 10.

36.

Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S; Frequent Hemodialysis Network (FHN) Trial Group.

Circ Cardiovasc Imaging. 2012 Mar;5(2):251-61. doi: 10.1161/CIRCIMAGING.111.969923. Epub 2012 Feb 23.

37.

Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study.

Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, Eknoyan G, Kusek JW, Herzog C, Cheung AK, Sarnak MJ.

Clin J Am Soc Nephrol. 2012 Jan;7(1):123-30. doi: 10.2215/CJN.06320611. Epub 2011 Nov 10.

38.

β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.

Tangri N, Shastri S, Tighiouart H, Beck GJ, Cheung AK, Eknoyan G, Sarnak MJ.

Am J Kidney Dis. 2011 Dec;58(6):939-45. doi: 10.1053/j.ajkd.2011.06.024. Epub 2011 Aug 27.

PMID:
21872979
39.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S.

Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213. Epub 2011 Jul 20.

40.

Use of aspirin associates with longer primary patency of hemodialysis grafts.

Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR Jr, Kusek JW, Feldman HI; Dialysis Access Consortium (DAC) Study Group.

J Am Soc Nephrol. 2011 Apr;22(4):773-81. doi: 10.1681/ASN.2010060582. Epub 2011 Mar 17.

41.

Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.

Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2011 Jan;57(1):90-100. doi: 10.1053/j.ajkd.2010.08.024. Epub 2010 Nov 30.

42.

In-center hemodialysis six times per week versus three times per week.

FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS.

N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.

43.

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.

Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK.

Circ Heart Fail. 2011 Jan;4(1):18-26. doi: 10.1161/CIRCHEARTFAILURE.109.932558. Epub 2010 Oct 29.

PMID:
21036889
44.

Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate.

Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, Greene T, Coresh J, Levey AS.

Kidney Int. 2011 Feb;79(4):471-7. doi: 10.1038/ki.2010.431. Epub 2010 Oct 27.

45.

Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS.

Clin J Am Soc Nephrol. 2011 Jan;6(1):184-91. doi: 10.2215/CJN.05030610. Epub 2010 Oct 21.

46.

Serum bicarbonate and long-term outcomes in CKD.

Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ.

Am J Kidney Dis. 2010 Nov;56(5):907-14. doi: 10.1053/j.ajkd.2010.03.023. Epub 2010 Jun 3.

PMID:
20605301
47.

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease.

Chawla V, Greene T, Beck GJ, Kusek JW, Collins AJ, Sarnak MJ, Menon V.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1582-7. doi: 10.2215/CJN.01450210. Epub 2010 Jun 17.

48.

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS.

Am J Kidney Dis. 2010 Sep;56(3):486-95. doi: 10.1053/j.ajkd.2010.03.026. Epub 2010 Jun 16.

49.

Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients.

Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, Beck GJ, Levey AS, Sarnak MJ.

Kidney Int. 2010 Apr;77(7):624-9. doi: 10.1038/ki.2009.524. Epub 2010 Jan 13.

50.

Effect of dipyridamole plus aspirin on hemodialysis graft patency.

Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI; DAC Study Group.

N Engl J Med. 2009 May 21;360(21):2191-201. doi: 10.1056/NEJMoa0805840.

Supplemental Content

Support Center